2021
DOI: 10.1016/j.ijbiomac.2020.11.129
|View full text |Cite
|
Sign up to set email alerts
|

Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(15 citation statements)
references
References 27 publications
1
14
0
Order By: Relevance
“…[36]. Similar actions were obtained with QPS-modified glycol-chitosan polymer microspheres [37] and QPS-functionalized epigallocatechin gallate capped gold nanoparticles [38].…”
Section: Introductionsupporting
confidence: 66%
“…[36]. Similar actions were obtained with QPS-modified glycol-chitosan polymer microspheres [37] and QPS-functionalized epigallocatechin gallate capped gold nanoparticles [38].…”
Section: Introductionsupporting
confidence: 66%
“…Lee et al prepared the triphenylphosphonium-glycol chitosan derivative (GME-TPP) with 36% substitution by Michael addition. GME-TPP microspheres successfully targeted DOX delivery to mitochondria in cells, which indicated the microsphere possess great potential as effective drug delivery carrier [ 103 ]. Babii et al synthesized mannosyl chitosan with a degree of substitution of 15%.…”
Section: Polymersmentioning
confidence: 99%
“…Triphenylphosphine (TPP), with its high lipophilicity and delocalized positive charge, thus possessing both mitochondrial targeting and mitochondrial damaging functions, is the first small molecule applied to mitochondrial targeting. Till now, TPP has been extensively used to design various mitochondria-targeting nanosystems ( Wang R. et al, 2020 ; Lee et al, 2021 ; Sun et al, 2021 ). On the other hand, all-trans retinoic acid (RA), a metabolite of vitamin A, can bind to cellular retinoic acid-binding protein II (CRABP-II) very easily, and this tight-binder exhibits super affinity to the nuclear RA receptor, which allows for the precise nuclear targeting ( Majumdar et al, 2011 ; Zhou, et al, 2017 ; Ghyselinck and Duester., 2019 ).…”
Section: Mitochondria Targeting With the Aid Of Multifunctional Nanosystemsmentioning
confidence: 99%